Cargando…
KRAS oncogene in non-small cell lung cancer: clinical perspectives on the treatment of an old target
Lung neoplasms are the leading cause of death by cancer worldwide. Non-small cell lung cancer (NSCLC) constitutes more than 80% of all lung malignancies and the majority of patients present advanced disease at onset. However, in the last decade, multiple oncogenic driver alterations have been discov...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817724/ https://www.ncbi.nlm.nih.gov/pubmed/29455666 http://dx.doi.org/10.1186/s12943-018-0789-x |